Lan Fan, Cacicedo Jose M, Ruderman Neil, Ido Yasuo
Diabetes and Metabolism Research Unit, Department of Medicine, Section of Endocrinology, Boston University School of Medicine, Boston, Massachusetts 02118.
Diabetes and Metabolism Research Unit, Department of Medicine, Section of Endocrinology, Boston University School of Medicine, Boston, Massachusetts 02118; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118.
J Biol Chem. 2008 Oct 10;283(41):27628-27635. doi: 10.1074/jbc.M805711200. Epub 2008 Aug 7.
SIRT1, a histone/protein deacetylase, and AMP-activated protein kinase (AMPK) are key enzymes responsible for longevity and energy homeostasis. We examined whether a mechanistic connection exists between these molecules that involves the major AMPK kinase LKB1. Initial studies demonstrated that LKB1 is acetylated in cultured (HEK293T) cells, mouse white adipose tissue, and rat liver. In the 293T cells, SIRT1 overexpression diminished lysine acetylation of LKB1 and concurrently increased its activity, cytoplasmic/nuclear ratio, and association with the LKB1 activator STRAD. In contrast, short hairpin RNA for SIRT1, where studied, had opposite effects on these parameters. Mass spectrometric analysis established that acetylation of LKB1 occurs on multiple, but specific, lysine residues; however, only mutation of lysine 48 to arginine, which mimics deacetylation, reproduced all of the effects of activated SIRT1. SIRT1 also affected downstream targets of LKB1. Thus its overexpression increased AMPK and acetyl-CoA carboxylase phosphorylation, and conversely, RNA interference-mediated SIRT1 knockdown reduced AMPK phosphorylation and that of another LKB1 target MARK1. Consistent with the results in cultured cells, total LKB1 lysine acetylation was decreased by 60% in the liver of 48-h starved rats compared with starved-refed rats, and this was associated with modest but significant increases in both LKB1 and AMPK activities. These results suggest that LKB1 deacetylation is regulated by SIRT1 and that this in turn influences its intracellular localization, association with STRAD, kinase activity, and ability to activate AMPK.
沉默调节蛋白1(SIRT1)是一种组蛋白/蛋白质去乙酰化酶,与AMP激活的蛋白激酶(AMPK)都是负责维持寿命和能量稳态的关键酶。我们研究了这些分子之间是否存在涉及主要AMPK激酶LKB1的机制联系。初步研究表明,LKB1在培养的(HEK293T)细胞、小鼠白色脂肪组织和大鼠肝脏中发生乙酰化。在293T细胞中,SIRT1的过表达减少了LKB1的赖氨酸乙酰化,同时增加了其活性、细胞质/细胞核比例以及与LKB1激活剂STRAD的结合。相反,在进行研究的情况下,针对SIRT1的短发夹RNA对这些参数具有相反的影响。质谱分析确定,LKB1的乙酰化发生在多个特定的赖氨酸残基上;然而,只有将赖氨酸48突变为精氨酸(模拟去乙酰化)才能重现激活的SIRT1的所有效应。SIRT1还影响LKB1的下游靶点。因此,其过表达增加了AMPK和乙酰辅酶A羧化酶的磷酸化,相反,RNA干扰介导的SIRT1敲低降低了AMPK磷酸化以及另一个LKB1靶点MARK1的磷酸化。与培养细胞中的结果一致,与饥饿后再喂食的大鼠相比,饥饿48小时的大鼠肝脏中LKB1的总赖氨酸乙酰化降低了60%,这与LKB1和AMPK活性的适度但显著增加有关。这些结果表明,LKB1的去乙酰化受SIRT1调节,进而影响其细胞内定位、与STRAD的结合、激酶活性以及激活AMPK的能力。